Clinical Trials Directory

Trials / Unknown

UnknownNCT01655589

VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents

VEGF Gene Polymorphism and Response to Intravitreal Anti-VEGF Agents in Neovascular Age-related Macular Degeneration

Status
Unknown
Phase
Study type
Observational
Enrollment
74 (estimated)
Sponsor
Institute of Vision, Brasil · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to investigate the association between VEGF gene polymorphism and the response to intravitreal drugs in neovascular age-related macular degeneration. This is a retrospective review of patients treated between 2008 and 2012 at the Institute of Vision, in Belo Horizonte, Brazil.

Conditions

Timeline

Start date
2008-01-01
First posted
2012-08-02
Last updated
2012-08-02

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01655589. Inclusion in this directory is not an endorsement.

VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents (NCT01655589) · Clinical Trials Directory